CMIC HOLDINGS Co., Ltd. / Japan
台灣醫療科技展展位:n/a
CMIC Group pioneered the CRO business in Japan over 28 years ago. Since then CMIC has continued as a leading innovator in the industry and has expanded services to encompass the entire pharmaceutical value-chain. We pride ourselves on meeting customers where they are and with exactly what they need to move their products forward. CMIC offers tailored solutions for pharmaceutical companies, medical device manufacturers, academia, bio-ventures and medical institutions. Using our collective strengths, we offer a broad range of services from preclinical research to practical applications with over 7,000 employees.
 
成立時間1992
資本額USD 27,500,000
員工數0
產品/服務類別
其他
採購與合作需求項目
Orphan drug which is in late stage development or marketed outside Japan. OrphanPacific, CMIC's affiliate, look for in licensing candidates.
供應與銷售項目
CRO (clinical and non-clinical), CMO, CSO services and MA holding as fee for service in Japan.
最新商機情報
你可能有興趣的產品服務
你可能有興趣的機構/企業
© Institute for Biotechnology and Medicine Industry & Research Center for Biotechnology and Medicine Policy
聯絡我們
Loading...